Across TCGA pan-cancer cohorts, RPL12P49 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RPL12P49’s most consistent transcriptional readouts.
The strongest signal is observed in rectum adenocarcinoma (READ), where RPL12P49 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL12P49 is over-expressed in tumor.
READ are the cancer types where RPL12P49 tumor–normal differential expression is most reproducible.